{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T12:56:02Z","timestamp":1789131362206,"version":"build-2803163510"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,16]],"date-time":"2021-08-16T00:00:00Z","timestamp":1629072000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014653","name":"Manchester Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014653","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004815","name":"Isaac Newton Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004815","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["G1002570"],"award-info":[{"award-number":["G1002570"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012617","name":"Moorfields Eye Hospital NHS Foundation Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012617","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012618","name":"NIHR Moorfields Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012618","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000305","name":"National Eye Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000305","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017645","name":"Moorfields Eye Charity","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017645","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["205041"],"award-info":[{"award-number":["205041"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001285","name":"UCL Institute of Ophthalmology, University College London","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001285","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000615","name":"Fight for Sight UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000615","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Nucleic Acids"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.omtn.2021.08.015","type":"journal-article","created":{"date-parts":[[2021,8,19]],"date-time":"2021-08-19T02:24:56Z","timestamp":1629339896000},"page":"432-443","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"special_numbering":"C","title":["CRISPR-Cas9 correction of OPA1 c.1334G>A: p.R445H restores mitochondrial homeostasis in dominant optic atrophy patient-derived iPSCs"],"prefix":"10.1016","volume":"26","author":[{"given":"Paul E.","family":"Sladen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2943-3515","authenticated-orcid":false,"given":"Pedro R.L.","family":"Perdig\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6607-4083","authenticated-orcid":false,"given":"Grace","family":"Salsbury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2394-4667","authenticated-orcid":false,"given":"Tatiana","family":"Novoselova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"van der Spuy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Paul","family":"Chapple","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7847-9320","authenticated-orcid":false,"given":"Patrick","family":"Yu-Wai-Man","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E.","family":"Cheetham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2021.08.015_bib1","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1016\/j.ophtha.2013.04.022","article-title":"Dominant optic atrophy: novel OPA1 mutations and revised prevalence estimates","volume":"120","author":"Yu-Wai-Man","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.omtn.2021.08.015_bib2","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1750-1172-7-46","article-title":"Dominant optic atrophy","volume":"7","author":"Lenaers","year":"2012","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.omtn.2021.08.015_bib3","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/eye.2011.2","article-title":"Pattern of retinal ganglion cell loss in dominant optic atrophy due to OPA1 mutations","volume":"25","author":"Yu-Wai-Man","year":"2011","journal-title":"Eye (Lond.)"},{"key":"10.1016\/j.omtn.2021.08.015_bib4","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/humu.22703","article-title":"Improved locus-specific database for OPA1 mutations allows inclusion of advanced clinical data","volume":"36","author":"Ferr\u00e9","year":"2015","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.omtn.2021.08.015_bib5","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1093\/brain\/awq007","article-title":"Multi-system neurological disease is common in patients with OPA1 mutations","volume":"133","author":"Yu-Wai-Man","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.omtn.2021.08.015_bib6","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1093\/hmg\/ddm079","article-title":"Opa1 deficiency in a mouse model of autosomal dominant optic atrophy impairs mitochondrial morphology, optic nerve structure and visual function","volume":"16","author":"Davies","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtn.2021.08.015_bib7","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1083\/jcb.200704110","article-title":"OPA1 processing controls mitochondrial fusion and is regulated by mRNA splicing, membrane potential, and Yme1L","volume":"178","author":"Song","year":"2007","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.omtn.2021.08.015_bib8","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1002\/ana.20681","article-title":"OPA1 R445H mutation in optic atrophy associated with sensorineural deafness","volume":"58","author":"Amati-Bonneau","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.omtn.2021.08.015_bib9","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1093\/brain\/awm335","article-title":"OPA1 mutations associated with dominant optic atrophy impair oxidative phosphorylation and mitochondrial fusion","volume":"131","author":"Zanna","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.omtn.2021.08.015_bib10","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1093\/brain\/awm005","article-title":"A splice site mutation in the murine Opa1 gene features pathology of autosomal dominant optic atrophy","volume":"130","author":"Alavi","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.omtn.2021.08.015_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/diseases5010001","article-title":"Mitochondrial Dynamics in Mitochondrial Diseases","volume":"5","author":"Su\u00e1rez-Rivero","year":"2017","journal-title":"Diseases"},{"key":"10.1016\/j.omtn.2021.08.015_bib12","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/cdd.2012.128","article-title":"Loss of OPA1 disturbs cellular calcium homeostasis and sensitizes for excitotoxicity","volume":"20","author":"Kushnareva","year":"2013","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.omtn.2021.08.015_bib13","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1016\/j.celrep.2017.05.073","article-title":"OPA1 Isoforms in the Hierarchical Organization of Mitochondrial Functions","volume":"19","author":"Del Dotto","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.omtn.2021.08.015_bib14","doi-asserted-by":"crossref","first-page":"180","DOI":"10.3389\/fcell.2020.00180","article-title":"OPA1-Exon4b Binds to mtDNA D-Loop for Transcriptional and Metabolic Modulation, Independent of Mitochondrial Fusion","volume":"8","author":"Yang","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.omtn.2021.08.015_bib15","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1212\/01.WNL.0000157282.76715.B1","article-title":"Mitochondrial DNA content is decreased in autosomal dominant optic atrophy","volume":"64","author":"Kim","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.omtn.2021.08.015_bib16","doi-asserted-by":"crossref","first-page":"e003012","DOI":"10.1161\/JAHA.112.003012","article-title":"OPA1 mutation and late-onset cardiomyopathy: mitochondrial dysfunction and mtDNA instability","volume":"1","author":"Chen","year":"2012","journal-title":"J.\u00a0Am. Heart Assoc."},{"key":"10.1016\/j.omtn.2021.08.015_bib17","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1093\/brain\/awm298","article-title":"OPA1 mutations induce mitochondrial DNA instability and optic atrophy \u2018plus\u2019 phenotypes","volume":"131","author":"Amati-Bonneau","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.omtn.2021.08.015_bib18","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1093\/hmg\/ddq209","article-title":"OPA1 mutations cause cytochrome c oxidase deficiency due to loss of wild-type mtDNA molecules","volume":"19","author":"Yu-Wai-Man","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtn.2021.08.015_bib19","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1093\/brain\/awm272","article-title":"Mutation of OPA1 causes dominant optic atrophy with external ophthalmoplegia, ataxia, deafness and multiple mitochondrial DNA deletions: a novel disorder of mtDNA maintenance","volume":"131","author":"Hudson","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.omtn.2021.08.015_bib20","doi-asserted-by":"crossref","first-page":"101154","DOI":"10.1016\/j.isci.2020.101154","article-title":"Optic Atrophy 1 Controls Human Neuronal Development by Preventing Aberrant Nuclear DNA Methylation","volume":"23","author":"Caglayan","year":"2020","journal-title":"iScience"},{"key":"10.1016\/j.omtn.2021.08.015_bib21","doi-asserted-by":"crossref","first-page":"e230","DOI":"10.1093\/brain\/aws279","article-title":"Persistence of the treatment effect of idebenone in Leber\u2019s hereditary optic neuropathy","volume":"136","author":"Klopstock","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.omtn.2021.08.015_bib22","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/acn3.51026","article-title":"Idebenone increases chance of stabilization\/recovery of visual acuity in OPA1-dominant optic atrophy","volume":"7","author":"Romagnoli","year":"2020","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.omtn.2021.08.015_bib23","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.neuroscience.2016.01.042","article-title":"A randomized, placebo-controlled trial of the benzoquinone idebenone in a mouse model of OPA1-related dominant optic atrophy reveals a limited therapeutic effect on retinal ganglion cell dendropathy and visual function","volume":"319","author":"Smith","year":"2016","journal-title":"Neuroscience"},{"key":"10.1016\/j.omtn.2021.08.015_bib24","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/humu.20607","article-title":"Comprehensive cDNA study and quantitative transcript analysis of mutant OPA1 transcripts containing premature termination codons","volume":"29","author":"Schimpf","year":"2008","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.omtn.2021.08.015_bib25","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1038\/s41598-018-20838-8","article-title":"OPA1 gene therapy prevents retinal ganglion cell loss in a Dominant Optic Atrophy mouse model","volume":"8","author":"Sarzi","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtn.2021.08.015_bib26","doi-asserted-by":"crossref","first-page":"15927","DOI":"10.1073\/pnas.0407043101","article-title":"OPA1 requires mitofusin 1 to promote mitochondrial fusion","volume":"101","author":"Cipolat","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2021.08.015_bib27","doi-asserted-by":"crossref","first-page":"eaaz7423","DOI":"10.1126\/scitranslmed.aaz7423","article-title":"Bilateral visual improvement with unilateral gene therapy injection for Leber hereditary optic neuropathy","volume":"12","author":"Yu-Wai-Man","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omtn.2021.08.015_bib28","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.ophtha.2020.12.012","article-title":"Efficacy and Safety of Intravitreal Gene Therapy for Leber Hereditary Optic Neuropathy Treated within 6 Months of Disease Onset","volume":"128","author":"Newman","year":"2021","journal-title":"Ophthalmology"},{"key":"10.1016\/j.omtn.2021.08.015_bib29","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/s41587-020-0561-9","article-title":"Genome editing with CRISPR-Cas nucleases, base editors, transposases and prime editors","volume":"38","author":"Anzalone","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2021.08.015_bib30","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1093\/hmg\/ddu509","article-title":"Translational read-through of the RP2 Arg120stop mutation in patient iPSC-derived retinal pigment epithelium cells","volume":"24","author":"Schwarz","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtn.2021.08.015_bib31","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/nbt.3481","article-title":"Enhancing homology-directed genome editing by catalytically active and inactive CRISPR-Cas9 using asymmetric donor DNA","volume":"34","author":"Richardson","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2021.08.015_bib32","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/nature17664","article-title":"Efficient introduction of specific homozygous and heterozygous mutations using CRISPR\/Cas9","volume":"533","author":"Paquet","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2021.08.015_bib33","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/nbt.2647","article-title":"DNA targeting specificity of RNA-guided Cas9 nucleases","volume":"31","author":"Hsu","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2021.08.015_bib34","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/nbt.3437","article-title":"Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9","volume":"34","author":"Doench","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2021.08.015_bib35","series-title":"CRISPR Gene Editing: Methods and Protocols","first-page":"29","article-title":"Rapid Quantitative Evaluation of CRISPR Genome Editing by TIDE and TIDER","author":"Brinkman","year":"2019"},{"key":"10.1016\/j.omtn.2021.08.015_bib36","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.acthis.2017.03.001","article-title":"A simple ImageJ macro tool for analyzing mitochondrial network morphology in mammalian cell culture","volume":"119","author":"Valente","year":"2017","journal-title":"Acta Histochem."},{"key":"10.1016\/j.omtn.2021.08.015_bib38","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1146\/annurev.bi.65.070196.003023","article-title":"Crosstalk between nuclear and mitochondrial genomes","volume":"65","author":"Poyton","year":"1996","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.omtn.2021.08.015_bib39","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nm.3793","article-title":"Therapeutic genome editing: prospects and challenges","volume":"21","author":"Cox","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtn.2021.08.015_bib40","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.mito.2007.06.004","article-title":"Mammalian mitochondrial nucleoids: organizing an independently minded genome","volume":"7","author":"Holt","year":"2007","journal-title":"Mitochondrion"},{"key":"10.1016\/j.omtn.2021.08.015_bib41","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/ng1769","article-title":"High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease","volume":"38","author":"Bender","year":"2006","journal-title":"Nat. Genet."},{"key":"10.1016\/j.omtn.2021.08.015_bib42","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1136\/jmg.39.3.162","article-title":"Leber hereditary optic neuropathy","volume":"39","author":"Yu-Wai-Man","year":"2002","journal-title":"J.\u00a0Med. Genet."},{"key":"10.1016\/j.omtn.2021.08.015_bib43","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.tig.2017.11.001","article-title":"Mitochondrial Genome Engineering: The Revolution May Not Be CRISPR-Ized","volume":"34","author":"Gammage","year":"2018","journal-title":"Trends Genet."},{"key":"10.1016\/j.omtn.2021.08.015_bib44","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/s41586-020-2477-4","article-title":"A bacterial cytidine deaminase toxin enables CRISPR-free mitochondrial base editing","volume":"583","author":"Mok","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2021.08.015_bib45","doi-asserted-by":"crossref","first-page":"4340","DOI":"10.1093\/hmg\/ddx320","article-title":"LRRK2 G2019S-induced mitochondrial DNA damage is LRRK2 kinase dependent and inhibition restores mtDNA integrity in Parkinson\u2019s disease","volume":"26","author":"Howlett","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtn.2021.08.015_bib46","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.nbd.2013.10.013","article-title":"LRRK2 mutations cause mitochondrial DNA damage in iPSC-derived neural cells from Parkinson\u2019s disease patients: reversal by gene correction","volume":"62","author":"Sanders","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.omtn.2021.08.015_bib47","doi-asserted-by":"crossref","first-page":"E87","DOI":"10.1152\/ajpendo.00457.2019","article-title":"A pipeline for multidimensional confocal analysis of mitochondrial morphology, function, and dynamics in pancreatic \u03b2-cells","volume":"318","author":"Chaudhry","year":"2020","journal-title":"Am. J. Physiol. Endocrinol. Metab."}],"container-title":["Molecular Therapy - Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253121002092?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253121002092?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T01:30:36Z","timestamp":1761874236000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253121002092"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":46,"alternative-id":["S2162253121002092"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2021.08.015","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CRISPR-Cas9 correction of OPA1 c.1334G>A: p.R445H restores mitochondrial homeostasis in dominant optic atrophy patient-derived iPSCs","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2021.08.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s).","name":"copyright","label":"Copyright"}]}}